Potential of nanoformulations in malaria treatment

Malaria is caused by the protozoan Plasmodium sp and affects millions of people worldwide. Its clinical form ranges from asymptomatic to potentially fatal and severe. Current treatments include single drugs such as chloroquine, lumefantrine, primaquine, or in combination with artemisinin or its deri...

Descripción completa

Detalles Bibliográficos
Autores principales: Chaves, Janaina Braga, Portugal Tavares de Moraes, Bianca, Regina Ferrarini, Stela, Noé da Fonseca, Francisco, Silva, Adriana Ribeiro, Gonçalves-de-Albuquerque, Cassiano Felippe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9645116/
https://www.ncbi.nlm.nih.gov/pubmed/36386185
http://dx.doi.org/10.3389/fphar.2022.999300

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9645116/
https://www.ncbi.nlm.nih.gov/pubmed/36386185
http://dx.doi.org/10.3389/fphar.2022.999300

Ejemplares similares